Current views on type 2 diabetes.
暂无分享,去创建一个
Zhongjie Sun | Yi Lin | Zhongjie Sun | Yi Lin
[1] Asker E Jeukendrup,et al. Physical inactivity and obesity: links with insulin resistance and type 2 diabetes mellitus , 2009, Diabetes/metabolism research and reviews.
[2] D. Leroith,et al. A molecular basis for insulin resistance. Elevated serine/threonine phosphorylation of IRS-1 and IRS-2 inhibits their binding to the juxtamembrane region of the insulin receptor and impairs their ability to undergo insulin-induced tyrosine phosphorylation. , 2009, The Journal of biological chemistry.
[3] R. Seeley,et al. Targeting the CNS to treat type 2 diabetes , 2009, Nature Reviews Drug Discovery.
[4] J. Florez,et al. Clinical translation of genetic predictors for type 2 diabetes , 2009, Current opinion in endocrinology, diabetes, and obesity.
[5] Leif Groop,et al. Genetic dissection of type 2 diabetes , 2009, Molecular and Cellular Endocrinology.
[6] S. Mcphee,et al. Current Medical Diagnosis and Treatment , 2009, Journal of Nuclear Medicine.
[7] V. Randhawa,et al. Insulin action on glucose transporters through molecular switches, tracks and tethers. , 2008, The Biochemical journal.
[8] H. Häring,et al. How insulin receptor substrate proteins regulate the metabolic capacity of the liver--implications for health and disease. , 2008, Current medicinal chemistry.
[9] M. Cuttle,et al. Insulin-triggered repositioning of munc18c on syntaxin-4 in GLUT4 signalling. , 2008, The Biochemical journal.
[10] M. White,et al. Insulin-like signaling, nutrient homeostasis, and life span. , 2008, Annual review of physiology.
[11] T. Asano,et al. Role of phosphatidylinositol 3-kinase activation on insulin action and its alteration in diabetic conditions. , 2007, Biological & pharmaceutical bulletin.
[12] P. Ramarao,et al. Animal models in type 2 diabetes research: an overview. , 2007, The Indian journal of medical research.
[13] M. Lawrence,et al. The insulin and EGF receptor structures: new insights into ligand-induced receptor activation. , 2007, Trends in biochemical sciences.
[14] R. Wolfe,et al. Contraction of insulin-resistant muscle normalizes insulin action in association with increased mitochondrial activity and fatty acid catabolism. , 2007, American journal of physiology. Cell physiology.
[15] S. Kahn,et al. Mechanisms linking obesity to insulin resistance and type 2 diabetes , 2006, Nature.
[16] D. James,et al. Molecular Dissection of the Munc18c/Syntaxin4 Interaction: Implications for Regulation of Membrane Trafficking , 2006, Traffic.
[17] M. Lawrence,et al. Structure of the insulin receptor ectodomain reveals a folded-over conformation , 2006, Nature.
[18] Reinhard Jahn,et al. SNAREs — engines for membrane fusion , 2006, Nature Reviews Molecular Cell Biology.
[19] S. Elbein,et al. The Genetic Basis of Type 2 Diabetes. , 2006, Cellscience.
[20] E. Lander,et al. Reactive oxygen species have a causal role in multiple forms of insulin resistance , 2006, Nature.
[21] G. Truett,et al. Development of insulin resistance and hyperphagia in Zucker fatty rats. , 2006, American journal of physiology. Regulatory, integrative and comparative physiology.
[22] C. Knauf,et al. Liver-specific deletion of insulin receptor substrate 2 does not impair hepatic glucose and lipid metabolism in mice , 2006, Diabetologia.
[23] Xueying Lin,et al. Irs1 and Irs2 signaling is essential for hepatic glucose homeostasis and systemic growth. , 2006, The Journal of clinical investigation.
[24] K. Petersen,et al. Reduced mitochondrial density and increased IRS-1 serine phosphorylation in muscle of insulin-resistant offspring of type 2 diabetic parents. , 2005, The Journal of clinical investigation.
[25] H. Kaneto,et al. Role of oxidative stress, endoplasmic reticulum stress, and c-Jun N-terminal kinase in pancreatic β-cell dysfunction and insulin resistance , 2005 .
[26] Nimesh Mody,et al. Serum retinol binding protein 4 contributes to insulin resistance in obesity and type 2 diabetes , 2005, Nature.
[27] R. DeFronzo,et al. Dose-response effect of elevated plasma free fatty acid on insulin signaling. , 2005, Diabetes.
[28] K. Petersen,et al. Mitochondrial dysfunction and type 2 diabetes , 2005, Current diabetes reports.
[29] K. Wellen,et al. Inflammation, stress, and diabetes. , 2005, The Journal of clinical investigation.
[30] G. Lutty,et al. Neutrophils are associated with capillary closure in spontaneously diabetic monkey retinas. , 2005, Diabetes.
[31] Michael Stumvoll,et al. Type 2 diabetes: principles of pathogenesis and therapy , 2005, The Lancet.
[32] R. Gimeno,et al. Adipose tissue as an active endocrine organ: recent advances. , 2005, Current opinion in pharmacology.
[33] J. Zierath,et al. Insulin signal transduction in human skeletal muscle: identifying the defects in Type II diabetes. , 2005, Biochemical Society transactions.
[34] C. Taniguchi,et al. Complementary roles of IRS-1 and IRS-2 in the hepatic regulation of metabolism. , 2005, The Journal of clinical investigation.
[35] P. Iyengar,et al. The Hyperglycemia-induced Inflammatory Response in Adipocytes , 2005, Journal of Biological Chemistry.
[36] J. Miyazaki,et al. Adipocytes from Munc18c-null mice show increased sensitivity to insulin-stimulated GLUT4 externalization. , 2005, The Journal of clinical investigation.
[37] M. Lazar,et al. How Obesity Causes Diabetes: Not a Tall Tale , 2005, Science.
[38] Christopher J. Rhodes,et al. Type 2 Diabetes-a Matter of ß-Cell Life and Death? , 2005, Science.
[39] Morihiro Matsuda,et al. Increased oxidative stress in obesity and its impact on metabolic syndrome. , 2004, The Journal of clinical investigation.
[40] Xueying Lin,et al. Dysregulation of insulin receptor substrate 2 in beta cells and brain causes obesity and diabetes. , 2004, The Journal of clinical investigation.
[41] J. Manson,et al. Relationship of physical activity vs body mass index with type 2 diabetes in women. , 2004, JAMA.
[42] S. Shoelson,et al. Insulin Resistance Due to Phosphorylation of Insulin Receptor Substrate-1 at Serine 302* , 2004, Journal of Biological Chemistry.
[43] D. Accili. Lilly lecture 2003: the struggle for mastery in insulin action: from triumvirate to republic. , 2004, Diabetes.
[44] R. Mooney,et al. Hepatocytes: critical for glucose homeostasis. , 2004, The international journal of biochemistry & cell biology.
[45] K. Petersen,et al. Impaired mitochondrial activity in the insulin-resistant offspring of patients with type 2 diabetes. , 2004, The New England journal of medicine.
[46] P. Halban,et al. Decreased beta-cell mass in diabetes: significance, mechanisms and therapeutic implications , 2004, Diabetologia.
[47] M. White. Insulin Signaling in Health and Disease , 2003, Science.
[48] Sunmin Park,et al. Upregulation of insulin receptor substrate-2 in pancreatic beta cells prevents diabetes. , 2003, The Journal of clinical investigation.
[49] E. Gabazza,et al. Oxidative stress is associated with adiposity and insulin resistance in men. , 2003, The Journal of clinical endocrinology and metabolism.
[50] C. Kahn,et al. Tissue-specific Ablation of the GLUT4 Glucose Transporter or the Insulin Receptor Challenges Assumptions about Insulin Action and Glucose Homeostasis* , 2003, Journal of Biological Chemistry.
[51] Kathrin Maedler,et al. Inflammatory mediators and islet β-cell failure: a link between type 1 and type 2 diabetes , 2003, Journal of Molecular Medicine.
[52] M. Daly,et al. PGC-1α-responsive genes involved in oxidative phosphorylation are coordinately downregulated in human diabetes , 2003, Nature Genetics.
[53] A. Butte,et al. Coordinated reduction of genes of oxidative metabolism in humans with insulin resistance and diabetes: Potential role of PGC1 and NRF1 , 2003, Proceedings of the National Academy of Sciences of the United States of America.
[54] Kumar Sharma,et al. Diabetic kidney disease in the db/db mouse. , 2003, American journal of physiology. Renal physiology.
[55] A. Belfiore,et al. Signaling differences from the A and B isoforms of the insulin receptor (IR) in 32D cells in the presence or absence of IR substrate-1. , 2003, Endocrinology.
[56] C. Kahn,et al. Insulin signaling is required for insulin's direct and indirect action on hepatic glucose production. , 2003, The Journal of clinical investigation.
[57] S. Kahn,et al. The relative contributions of insulin resistance and beta-cell dysfunction to the pathophysiology of Type 2 diabetes , 2003, Diabetologia.
[58] G. Shulman,et al. Mechanism by Which Fatty Acids Inhibit Insulin Activation of Insulin Receptor Substrate-1 (IRS-1)-associated Phosphatidylinositol 3-Kinase Activity in Muscle* , 2002, The Journal of Biological Chemistry.
[59] D. Ron,et al. Endoplasmic reticulum stress and the development of diabetes: a review. , 2002, Diabetes.
[60] N. Ruderman,et al. Lipid-Induced Insulin Resistance in Human Muscle Is Associated With Changes in Diacylglycerol, Protein Kinase C, and IκB-α , 2002 .
[61] C. Kahn,et al. Knockout models are useful tools to dissect the pathophysiology and genetics of insulin resistance , 2002, Clinical endocrinology.
[62] H. Lodish,et al. Nomenclature of the GLUT/SLC2A family of sugar/polyol transport facilitators. , 2002, American journal of physiology. Endocrinology and metabolism.
[63] A. Baudry,et al. Genetic manipulation of insulin signaling, action and secretion in mice , 2002, EMBO reports.
[64] Jiong Wu,et al. Molecular Mechanism of Insulin-Induced Degradation of Insulin Receptor Substrate 1 , 2002, Molecular and Cellular Biology.
[65] R. Robertson,et al. Minireview: Secondary β-Cell Failure in Type 2 Diabetes-A Convergence of Glucotoxicity and Lipotoxicity. , 2002, Endocrinology.
[66] M. White,et al. Phosphorylation of Ser307 in Insulin Receptor Substrate-1 Blocks Interactions with the Insulin Receptor and Inhibits Insulin Action* , 2002, The Journal of Biological Chemistry.
[67] J. Shaw,et al. Global and societal implications of the diabetes epidemic , 2001, Nature.
[68] D. Withers,et al. Insulin receptor substrate proteins and neuroendocrine function. , 2001, Biochemical Society transactions.
[69] G. Shulman,et al. Adipose-selective targeting of the GLUT4 gene impairs insulin action in muscle and liver , 2001, Nature.
[70] W. Saris,et al. Impaired oxidation of plasma-derived fatty acids in type 2 diabetic subjects during moderate-intensity exercise. , 2000, Diabetes.
[71] J. Schlessinger,et al. Cell Signaling by Receptor Tyrosine Kinases , 2000, Cell.
[72] J. Schlessinger. Cell Signaling by Receptor Tyrosine Kinases , 2000, Cell.
[73] L. Foster,et al. Mechanism and regulation of GLUT-4 vesicle fusion in muscle and fat cells. , 2000, American journal of physiology. Cell physiology.
[74] J. Rothman,et al. Compartmental specificity of cellular membrane fusion encoded in SNARE proteins , 2000, Nature.
[75] D. Moller. Potential Role of TNF-α in the Pathogenesis of Insulin Resistance and Type 2 Diabetes , 2000, Trends in Endocrinology & Metabolism.
[76] C. Kahn,et al. Targeted disruption of the glucose transporter 4 selectively in muscle causes insulin resistance and glucose intolerance , 2000, Nature Medicine.
[77] J. Zierath,et al. Insulin action and insulin resistance in human skeletal muscle , 2000, Diabetologia.
[78] B. Wolffenbuttel,et al. Plasma FFA utilization and fatty acid-binding protein content are diminished in type 2 diabetic muscle. , 2000, American journal of physiology. Endocrinology and metabolism.
[79] C. Kahn,et al. Loss of insulin signaling in hepatocytes leads to severe insulin resistance and progressive hepatic dysfunction. , 2000, Molecular cell.
[80] K. Yamasawa,et al. Intraperitoneally implanted artificial pancrease with transkaryotic beta-cells on microcarrier beads in a diffusion chamber improves hyperglycemia after 90% pancreatectomy in rats. , 2000, In vivo.
[81] L. Mandarino,et al. Fuel selection in human skeletal muscle in insulin resistance: a reexamination. , 2000, Diabetes.
[82] L. Gianaroli,et al. ifferential expression and regulation of brain-derived neurotrophic factor BDNF ) mRNA isoforms in androgen-sensitive motoneurons of the rat lumbar pinal cord , 2010 .
[83] M. Kasuga,et al. Role of SNAP23 in Insulin-induced Translocation of GLUT4 in 3T3-L1 Adipocytes , 2000, The Journal of Biological Chemistry.
[84] P. Ramarao,et al. Insulin resistance: current therapeutic approaches. , 1999, Drugs of today.
[85] E. Ziv,et al. Nutritionally Induced Insulin Resistance and Receptor Defect Leading to β‐Cell Failure in Animal Models , 1999, Annals of the New York Academy of Sciences.
[86] D. M. Rocha,et al. Overnight lowering of free fatty acids with Acipimox improves insulin resistance and glucose tolerance in obese diabetic and nondiabetic subjects. , 1999, Diabetes.
[87] B. Kahn,et al. Glucose transporters and insulin action--implications for insulin resistance and diabetes mellitus. , 1999, The New England journal of medicine.
[88] G. Boden. Free fatty acids, insulin resistance, and type 2 diabetes mellitus. , 1999, Proceedings of the Association of American Physicians.
[89] B. Kennedy,et al. Increased insulin sensitivity and obesity resistance in mice lacking the protein tyrosine phosphatase-1B gene. , 1999, Science.
[90] C. Kahn,et al. Tissue-Specific Knockout of the Insulin Receptor in Pancreatic β Cells Creates an Insulin Secretory Defect Similar to that in Type 2 Diabetes , 1999, Cell.
[91] J. Pessin,et al. Regulation of Insulin-stimulated GLUT4 Translocation by Munc18c in 3T3L1 Adipocytes* , 1998, The Journal of Biological Chemistry.
[92] E. Ferrannini. Insulin resistance versus insulin deficiency in non-insulin-dependent diabetes mellitus: problems and prospects. , 1998, Endocrine reviews.
[93] R. Farese,et al. Evidence for Involvement of Protein Kinase C (PKC)-ζ and Noninvolvement of Diacylglycerol-Sensitive PKCs in Insulin-Stimulated Glucose Transport in L6 Myotubes. , 1997, Endocrinology.
[94] R A Roth,et al. Protein kinase C modulation of insulin receptor substrate-1 tyrosine phosphorylation requires serine 612. , 1997, Biochemistry.
[95] D. Accili,et al. Growth-promoting interaction of IGF-II with the insulin receptor during mouse embryonic development. , 1997, Developmental biology.
[96] G. Dohm,et al. Alterations in skeletal muscle protein-tyrosine phosphatase activity and expression in insulin-resistant human obesity and diabetes. , 1997, The Journal of clinical investigation.
[97] C. Mastick,et al. Association of N-Ethylmaleimide Sensitive Fusion (NSF) Protein and Soluble NSF Attachment Proteins-α and -γ with Glucose Transporter-4-Containing Vesicles in Primary Rat Adipocytes. , 1997, Endocrinology.
[98] R. Vigneri,et al. Increased adipose tissue PC-1 protein content, but not tumour necrosis factor-a gene expression, is associated with a reduction of both whole body insulin sensitivity and insulin receptor tyrosine-kinase activity , 1997, Diabetologia.
[99] J. Chernoff,et al. Protein-Tyrosine Phosphatase 1B Complexes with the Insulin Receptor in Vivo and Is Tyrosine-phosphorylated in the Presence of Insulin* , 1997, The Journal of Biological Chemistry.
[100] H. Beck-Nielsen,et al. Altered basal and insulin-stimulated phosphotyrosine phosphatase (PTPase) activity in skeletal muscle from NIDDM patients compared with control subjects , 1996, Diabetologia.
[101] B. Spiegelman,et al. IRS-1-Mediated Inhibition of Insulin Receptor Tyrosine Kinase Activity in TNF-α- and Obesity-Induced Insulin Resistance , 1996, Science.
[102] William Arbuthnot Sir Lane,et al. Role of IRS-2 in insulin and cytokine signalling , 1995, Nature.
[103] S. Hubbard,et al. Crystal structure of the tyrosine kinase domain of the human insulin receptor , 1994, Nature.
[104] J. Simoneau,et al. Impaired free fatty acid utilization by skeletal muscle in non-insulin-dependent diabetes mellitus. , 1994, The Journal of clinical investigation.
[105] C. Kahn,et al. Alternative pathway of insulin signalling in mice with targeted disruption of the IRS-1 gene , 1994, Nature.
[106] C. Kahn,et al. The insulin signaling system. , 1994, The Journal of biological chemistry.
[107] M. Mueckler,et al. Evidence from transgenic mice that glucose transport is rate-limiting for glycogen deposition and glycolysis in skeletal muscle. , 1993, The Journal of biological chemistry.
[108] E. Shafrir,et al. Animal models of non-insulin-dependent diabetes. , 1992, Diabetes/metabolism reviews.
[109] R. DeFronzo,et al. Pathogenesis of NIDDM: A Balanced Overview , 1992, Diabetes Care.
[110] D. James,et al. Differential regulation of two distinct glucose transporter species expressed in 3T3-L1 adipocytes: effect of chronic insulin and tolbutamide treatment. , 1989, Proceedings of the National Academy of Sciences of the United States of America.
[111] R. Hye,et al. Animal models of diabetes mellitus: physiology and pathology. , 1983, The Journal of surgical research.
[112] N. Rakieten,et al. Studies on the diabetogenic action of streptozotocin (NSC-37917). , 1963, Cancer chemotherapy reports.
[113] K. Narayan,et al. Clinical risk factors, DNA variants, and the development of type 2 diabetes. , 2009, The New England journal of medicine.
[114] G. Ramadori,et al. Carbohydrate metabolism and the liver: actual aspects from physiology and disease. , 2007, Zeitschrift fur Gastroenterologie.
[115] J. Olefsky,et al. Stressed out about obesity and insulin resistance , 2006, Nature Medicine.
[116] W. Cefalu. Animal models of type 2 diabetes: clinical presentation and pathophysiological relevance to the human condition. , 2006, ILAR journal.
[117] H. Kaneto,et al. Role of oxidative stress, endoplasmic reticulum stress, and c-Jun N-terminal kinase in pancreatic beta-cell dysfunction and insulin resistance. , 2006, The international journal of biochemistry & cell biology.
[118] C. Rhodes. Type 2 diabetes-a matter of beta-cell life and death? , 2005, Science.
[119] N. Ruderman,et al. Lipid-induced insulin resistance in human muscle is associated with changes in diacylglycerol, protein kinase C, and IkappaB-alpha. , 2002, Diabetes.
[120] R. Robertson,et al. Minireview: Secondary beta-cell failure in type 2 diabetes--a convergence of glucotoxicity and lipotoxicity. , 2002, Endocrinology.
[121] C. Wollheim,et al. Mitochondrial function in normal and diabetic beta-cells. , 2001, Nature.
[122] D. Moller. Potential role of TNF-alpha in the pathogenesis of insulin resistance and type 2 diabetes. , 2000, Trends in endocrinology and metabolism: TEM.
[123] R. Farese,et al. Evidence for involvement of protein kinase C (PKC)-zeta and noninvolvement of diacylglycerol-sensitive PKCs in insulin-stimulated glucose transport in L6 myotubes. , 1997, Endocrinology.
[124] C. Mastick,et al. Association of N-ethylmaleimide sensitive fusion (NSF) protein and soluble NSF attachment proteins-alpha and -gamma with glucose transporter-4-containing vesicles in primary rat adipocytes. , 1997, Endocrinology.
[125] Mark D. Johnson,et al. Early neonatal death in mice homozygous for a null allele of the insulin receptor gene , 1996, Nature Genetics.
[126] B. Spiegelman,et al. Adipose expression of tumor necrosis factor-alpha: direct role in obesity-linked insulin resistance. , 1993, Science.
[127] J. Schlessinger,et al. Signaling by Receptor Tyrosine Kinases , 1993 .
[128] S. Pirt. Genetic manipulation , 1976, Nature.